PATENT CLAIM ANALYSIS

Application Number: 15760284
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "210210"]

Abstract:
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Claim (Index 14):
The compound of  claim 1 , wherein R 77  is selected from the group consisting of H, CH 3  and CF 3 .

Metadata:
- Claim Count in Document: 25.0
- Percentile: 90.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15125911', '15760343', '15030378', '15566633', '12785665']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8356411560241931
- 35 USC 102 Novelty (BERT): 0.5478092056628387
- Combined Prediction Score: 0.8068579609880577
- Mean Citation Score: 360.872362
- Max Citation Score: 418.14563
- Similarity Product: 326.31672815547114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test